Product NDC: | 63402-510 |
Proprietary Name: | Xopenex HFA |
Non Proprietary Name: | levalbuterol tartrate |
Active Ingredient(s): | 45 ug/1 & nbsp; levalbuterol tartrate |
Administration Route(s): | ORAL |
Dosage Form(s): | AEROSOL, METERED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63402-510 |
Labeler Name: | Sunovion Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021730 |
Marketing Category: | NDA |
Start Marketing Date: | 20051201 |
Package NDC: | 63402-510-03 |
Package Description: | 1 INHALER in 1 CARTON (63402-510-03) > 80 AEROSOL, METERED in 1 INHALER |
NDC Code | 63402-510-03 |
Proprietary Name | Xopenex HFA |
Package Description | 1 INHALER in 1 CARTON (63402-510-03) > 80 AEROSOL, METERED in 1 INHALER |
Product NDC | 63402-510 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | levalbuterol tartrate |
Dosage Form Name | AEROSOL, METERED |
Route Name | ORAL |
Start Marketing Date | 20051201 |
Marketing Category Name | NDA |
Labeler Name | Sunovion Pharmaceuticals Inc. |
Substance Name | LEVALBUTEROL TARTRATE |
Strength Number | 45 |
Strength Unit | ug/1 |
Pharmaceutical Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |